Indications and uses
For the treatment of symptoms of herpes
For the treatment of symptoms of herpes
Adults and children 12 years or over: Wash hands before and after applying Terragen. Apply to affected area at the first sign of an outbreak or tingling sensation. Early treatment ensures the best results. Rub in gently but completely. Do not use more than 3 times a day. Children under 12 years: ask a doctor. Store at room temperature.
Graphites, Natrum Muriaticum, Ranunculus Bulbosus, Thuja Occidentalis
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States
Graphites - Relief for skin erruptions in genital area
Natrum Muriaticum - Blisters, itching and burning relief
Ranunculus Bulbosus - Herpes blisters, stinging pain relief
Thuja Occidentalis - Herpes, skin erruptions, burning pain relief
For the treatment of symptoms of herpes
For external use only.
Virally based infections are contagious. This product will not stop the spread of the herpes virus or other viruses.
Do not use - in the eyes - over large areas of the body - if you are allergic to any ingredient in this product.
Ask a doctor before use if pregnant or nursing.
Stop use and ask a doctor if condition worsens or symptoms persist for more than 7 days.
Adults and children 12 years or over: Wash hands before and after applying Terragen. Apply to affected area at the first sign of an outbreak or tingling sensation. Early treatment ensures the best results. Rub in gently but completely. Do not use more than 3 times a day. Children under 12 years: ask a doctor. Store at room temperature.
beeswax (organic), cotton seed oil, cedarwood oil, jojoba seed oil, magnesium oxide, silver oxide, stearic acid (naturally sourced), zinc oxide.
terragen™
HG FORMULA MAX
HG Treatment
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GRAPHITE | ACTIVE INGREDIENT | 4QQN74LH4O | 1 | |
| RANUNCULUS BULBOSUS | ACTIVE INGREDIENT | AEQ8NXJ0MB | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| GRAPHITE | ACTIVE MOIETY | 4QQN74LH4O | 1 | |
| RANUNCULUS BULBOSUS | ACTIVE MOIETY | AEQ8NXJ0MB | 1 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 1 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| JUNIPERUS VIRGINIANA OIL | INACTIVE INGREDIENT | PAD4FN7P2G | 1 | |
| MAGNESIUM OXIDE | INACTIVE INGREDIENT | 3A3U0GI71G | 1 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 1 | |
| WHITE WAX | INACTIVE INGREDIENT | 7G1J5DA97F | 1 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24909-143 | 24909-143-14, 24909-143-15, 24909-143-44, 24909-143-50 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| COTTONSEED OIL | H3E878020N | IACT |
| JOJOBA OIL | 724GKU717M | IACT |
| JUNIPERUS VIRGINIANA OIL | PAD4FN7P2G | IACT |
| MAGNESIUM OXIDE | 3A3U0GI71G | IACT |
| SILVER STEARATE | 4H6PCL92ZN | IACT |
| WHITE WAX | 7G1J5DA97F | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
| GRAPHITE | 4QQN74LH4O | ACTIB |
| RANUNCULUS BULBOSUS | AEQ8NXJ0MB | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, DELAYED RELEASE / ORAL | 0.08 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET / ORAL | 5 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, DELAYED RELEASE / ORAL | 368 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | LOTION / TOPICAL | 1 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / TOPICAL | 500 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, EXTENDED RELEASE / ORAL | 75 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE, EXTENDED RELEASE / ORAL | 71 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, FILM COATED / ORAL | 80 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE / ORAL | 20 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, COATED / ORAL | 3 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | CAPSULE, DELAYED RELEASE / ORAL | 78 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET, EXTENDED RELEASE / ORAL | 25.74 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT, AUGMENTED / TOPICAL | 429 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM / VAGINAL | 40 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | AEROSOL, FOAM / TOPICAL | 2 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / SUBLINGUAL | 15 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | TABLET / ORAL | 63 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CAPSULE / ORAL | 79 mg | ||
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | 3A3U0GI71G | GUM, CHEWING / BUCCAL | 173 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | OINTMENT / TOPICAL | 2100 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | CREAM, AUGMENTED / TOPICAL | 10 %w/w | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | TABLET, EXTENDED RELEASE / ORAL | 14 mg | ||
| WHITE WAX | WHITE WAX | 7G1J5DA97F | SUPPOSITORY / RECTAL | 265 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 193cae2c-be99-5302-e063-6294a90adaaf | c8b3d0df-1db5-4c12-ae54-acdd19732fb0 | 2024-05-24 | Warnings | c8b3d0df-1db5-4c12-ae54-acdd19732fb0 |
Adverse event summaries are temporarily unavailable. Other product information remains available.